Market Cap | ₹2,780Cr |
ROE | 8.79% |
P/E Ratio(TTM) | 34.66 |
EPS(TTM) | 24.73 |
P/B Ratio | 3.15 |
Dividend Yield | 0.32% |
Industry P/E | 67.94 |
Book Value | 272.16 |
Debt to Equity | 0.23 |
Face Value | 5 |
Parent Organisation | Krsnaa Diagnostics |
Managing Director | Ms. Pallavi Bhatevara |
NSE Symbol | KRSNAA |
FUND NAME | AUM(%) |
---|---|
Tata Small Cap Fund Direct Growth | 1.78% |
Bandhan Small Cap Fund Direct Growth | 0.27% |
Tata India Pharma & Healthcare Fund Direct Growth | 0.08% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Dr Lal PathLabs | NA (0.00%) | 55.39 | ||
Metropolis Healthcare | NA (0.00%) | 70.91 | ||
Vijaya Diagnostic Centre | NA (0.00%) | 71.82 | ||
Thyrocare Technologies | NA (0.00%) | 60.67 |